EMJ Podcast: Insights For Healthcare Professionals

In this episode of Onc Now, Jonathan Stevenson explores the evolving field of orthopaedic oncology, highlighting the clinical challenges and innovations shaping the care of patients with bone and soft-tissue sarcomas. The conversation covers key hurdles in limb-salvage surgery, the ongoing challenge of prosthetic joint infection, and promising developments in translational research. He also shares insights into multidisciplinary collaboration, the vision behind future metastatic trials, and advice for the next generation of orthopaedic surgeons.

Timestamps:

00:00 - Introduction

02:16 - Overview of orthopaedic oncology challenges

08:40 - Pressing hurdles in limb-salvage surgery

13:27 – Prosthetic joint infections

17:00 - Promising developments in research

19:10 - Vision of NIHR metastatic trial

22:12 - Multidisciplinary care approach strategies

24:39 - Advice for early-career surgeons

26:22 - Transformative changes next decade

28:12 - Three 'magic wishes' for future care

In this first deep dive, Leslie Cho explores how lipidology and hormone therapy intersect in women's cardiovascular care. Drawing on major guideline work and trial data, she explains how clinicians should approach menopausal hormone therapy, complex lipid disorders, microvascular disease, and emerging therapies through a precision lens.

Timestamps:

01:10 – Menopausal hormone therapy

03:45 – Lipid-lowering therapy

05:55 – Microvascular disease

07:55 – Testosterone therapy

In this rapid-fire episode, Leslie Cho answers essential questions on women's cardiovascular health, from overlooked risk factors and lipid values to myths about chest pain, microvascular disease, menopause, and the future of precision cardiology.

In the final deep dive, Matteo Bassetti discusses antimicrobial resistance beyond the bedside: translating evidence into policy, the importance of national surveillance, lessons from sepsis and COVID-19, and the future of antibiotic innovation and hospital preparedness.

Timestamps:

01:24 – Translating evidence into policy

02:54 – National surveillance

04:15 – Sepsis and COVID-19

06:18 – Investment shortfalls

08:41 – Antibiotic crisis

10:19 – Looking ahead

In the second deep dive, Matteo Bassetti examines antibiotic stewardship where policy meets practice. He highlights gaps between guidelines and bedside realities, practical interventions for limited-resource settings, and balancing preservation of new antibiotics with effective treatment today.

Timestamps:

01:27 – Guideline gaps

04:40 – Encouraging stewardship

06:23 – Realistic interventions

09:59 – Antibiotic shortages

11:16 – Preserving new drugs

In this episode of Hema Now, Ana Boban discusses her vision as the incoming EAHAD President for 2026–2028. From her early experiences in haemophilia care to her leadership in European clinical trials and guideline development, she reflects on the future of bleeding disorders in Europe, highlighting the importance of supporting young clinicians and researchers, advancing clinical practice, and driving innovation in haemophilia care and research.

Timestamps:

00:00 – Introduction

01:38 - Vision for EAHAD Presidency

03:50 - Building on Past Leadership

06:45 - Key Priorities: Practice, Research, Education

09:05 - EAHAD Congress Highlights

11:20 - European Haemophilia Landscape Today

14:17 - Advances Influencing Clinical Care

16:14 - Unmet Needs in Europe

17:45 - Supporting Young Clinicians, Researchers

20:00 - Long-Term Goals Beyond 2028

TBC- Three Wishes for Haemophilia

1. In this first deep dive, Bassetti discusses the changing landscape of antimicrobial resistance in hospitals and ICUs, the challenges of multidrug-resistant Gram-negative bacteria, and the vulnerability of patients who are critically ill and immunocompromised. He explores how diagnosis, empiric therapy, and therapeutic monitoring influence outcomes and resistance.

Timestamps:

01:09 – Antimicrobial resistance trends

04:06 – Tackling sepsis

06:39 – Gram-negative threat

08:15 – Vulnerable populations

10:00 – Diagnosis and empiric therapy

12:14 – Dosing and pharmacokinetics

14:32 – Antibiotic allergies

Matteo Bassetti joins the EMJ Podcast for a rapid-fire discussion on antimicrobial resistance in hospitals. From prescribing pitfalls to early versus precise antibiotic use, he shares insights on howantimicrobial resistance is impacting real-world clinical care.

Drawing on her landmark work in HIV and vaccine research, Glenda Gray shares powerful lessons for tackling AMR in this last deep dive episode. From prevention and behavioural science to protecting high-risk populations, she explains how strategies that transformed HIV outcomes can inform a more effective and equitable AMR response.

Timestamps: 00:00 – Introduction

01:02 – Lessons from HIV

02:47 – Vaccine trials

03:50 – AMR interventions

05:17 – Behavioural science

06:31 – Key takeaways

In this second deep dive, Glenda Gray examines why the global antibiotic pipeline is failing and how access gaps are fuelling resistance. She discusses GARDP's mission-driven research and development model, the neglect of paediatric antibiotics, and how shortages of first-line treatments drive reliance on last-resort drugs, worsening the antimicrobial resistance crisis.

Timestamps: 00:00 – Introduction

00:58 – Antibiotic development

03:05 – GARDP's model

04:15 – Paediatric antibiotics

04:58 – Antibiotic shortages

05:50 – Access gaps